On Wednesday, Shares of Pfizer Inc. (NYSE:PFE), lost -1.75% to $31.96.
Pfizer declared that it has accomplished its acquisition of Hospira, Inc.
Pfizer’s GEP business now has a leadership position in the large and growing sterile injectables category, with a robust portfolio of both generic and branded products. The global market for generic sterile injectables is estimated to be $70 billion in 2020. In addition, GEP has significantly advanced its biosimilars business with a broadened portfolio of marketed products and pipeline assets, which will benefit from Pfizer’s best-in-class capabilities in monoclonal antibody development and manufacturing. The global market for biosimilars is estimated to be about $20 billion in 2020. The industry-leading medication administration systems business, which is now part of GEP, is a complementary business that benefits patients and healthcare systems through improved accuracy and productivity in clinical care. Pfizer is now poised to use its commercial capabilities, global scale, scientific expertise and manufacturing prowess, which now comprises two of the largest sterile injectable manufacturing facilities in the world, to maximize the global potential of its improved GEP portfolio of sterile injectables, biosimilars and medication administration systems.
Pfizer continues to expect the transaction to be right away accretive to adjusted diluted EPS1 upon closing and accretive by $0.10 - $0.12 per share in the first full year after the close, with additional accretion anticipated thereafter. In addition, Pfizer anticipates the transaction will deliver $800 million in annual cost synergies by 2018. Pfizer intends to update its 2015 financial guidance in the coming weeks to incorporate Hospira. The guidance will reflect the anticipated contribution from Hospira operations from the time of the completion of the Hospira merger to Pfizer’s fiscal year end, which is November 30, 2015 for Pfizer’s international fiscal year and December 31, 2015 for Pfizer’s U.S. fiscal year.
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments.
Shares of Cliffs Natural Resources Inc. (NYSE:CLF), inclined 2.10% to $4.38, during its last trading session.
First Point Minerals is happy to declare that it has reached a binding agreement with associated companies of Cliffs Natural Resources Inc. (CLF) (“Cliffs”) to purchase Cliffs’ 60% ownership of the Decar nickel project, located in central British Columbia, for an acquisition price of US$4.75 million.
Completion of the Transaction will result in First Point owning 100% of the Project, which comprises 60 claims covering about 24,500 hectares. “This purchase fulfills the long-held aspiration of First Point and its stakeholders of consolidating ownership of Decar, our flagship project,” said First Point President and CEO Jim Gilbert. “It will allow us to re-position the Project for advancement through the next phases of study and development, with a focus on a number of identified targets with noteworthy potential for exploration and economic upside.”
Cliffs Natural Resources Inc., a mining and natural resources company, produces iron ore and metallurgical coal. It operates five iron ore mines that produces iron ore pellets in Michigan and Minnesota; Koolyanobbing complex situated in northeast of the town of Southern Cross, which produces lump and fines iron ore; and two metallurgical coal mines located in Alabama and West Virginia. The company also owns interests in the Decar Property situated in British Columbia; and the Labrador Trough South property located in Fermont, Québec
Finally, Navient Corporation (NASDAQ:NAVI), ended its last trade with -0.08% loss, and closed at $12.29.
Navient, the nation’s leading loan administration, servicing and asset recovery company, has declared that Navient Foundation, the company-sponsored philanthropic fund, awarded a $5,600 grant to Community Action for Wyoming County. The organization is dedicated to meeting the needs of the area’s low-income and disadvantaged population.
“It is impossible for me to put into words the positive impact Navient Foundation’s generous gift has on the children and families in our community,” said Pat Standish, division director, Community Action for Wyoming County. “Without the support of Navient Foundation and Navient employees, who also give their valuable time as volunteers, thousands of people would have gone without assist.”
The grant award supports the organization’s Angel Action program, which provides assistance to those in need through volunteer donations and events.
Navient Corporation provides financial products and services in the United States. The company operates in four segments: FFELP Loans, Private Education Loans, Business Services, and Other.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
